High-dose cytosine arabinoside and idarubicin treatment of chronic myeloid leukemia in myeloid blast crisis.
about
Management of the advanced phases of chronic myelogenous leukemia in the era of tyrosine kinase inhibitors.Intensive chemotherapy in patients with chronic myelogenous leukaemia (CML) in accelerated or blastic phase--a report from the Swedish CML Group.Blast crisis in chronic myelogenous leukemia remains a difficult therapeutic challenge.
P2860
High-dose cytosine arabinoside and idarubicin treatment of chronic myeloid leukemia in myeloid blast crisis.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
High-dose cytosine arabinoside ...... kemia in myeloid blast crisis.
@en
High-dose cytosine arabinoside ...... kemia in myeloid blast crisis.
@nl
type
label
High-dose cytosine arabinoside ...... kemia in myeloid blast crisis.
@en
High-dose cytosine arabinoside ...... kemia in myeloid blast crisis.
@nl
prefLabel
High-dose cytosine arabinoside ...... kemia in myeloid blast crisis.
@en
High-dose cytosine arabinoside ...... kemia in myeloid blast crisis.
@nl
P2093
P2860
P356
P1476
High-dose cytosine arabinoside ...... kemia in myeloid blast crisis.
@en
P2093
P2860
P304
P356
10.1002/AJH.1089
P577
2001-06-01T00:00:00Z